Notes - Segment Information, Etc.

Oncolys BioPharma Inc. - Filing #7269903

Concept 2024-01-01 to
2024-12-31
Notes - Segment information, etc.
Notes - Segment information, etc.
Segment information
Description of fact that company's business comprises single segment
当社は、創薬事業の単一セグメントであるため、記載を省略しております。 

Talk to a Data Expert

Have a question? We'll get back to you promptly.